Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jorge Aparicio

Showing results (21-30 of 93) with videos related to

Pageof 10
Sort By:
Medical Oncology (Northwood, London, England)|October 5, 2006
Clinical predictors of severe toxicity in patients treated with combination chemotherapy with irinotecan and/or oxaliplatin for metastatic colorectal cancer: a single center experienceRoberto Díaz, Jorge Aparicio, Jorge Molina, et al.
Journal of Clinical Medicine|December 3, 2020
Metastatic Colorectal Cancer. First Line Therapy for Unresectable DiseaseJorge Aparicio, Francis Esposito, Sara Serrano, et al.
Ginekologia Polska|February 28, 2023
Metastatic gastric cancer in a full-term pregnancyJorge Aparicio-Ponce, Sandra Salcedo-Hermoza, Sandra Aparicio-Salcedo, et al.
JOP : Journal of the Pancreas|January 14, 2014
Management of advanced pancreatic cancer with gemcitabine plus erlotinib: efficacy and safety results in clinical practiceRobert Diaz Beveridge, Vicent Alcolea, Jorge Aparicio, et al.
Oncology|August 21, 2002
Multicenter phase I study of irinotecan plus raltitrexed in patients with 5-fluorouracil-refractory advanced colorectal cancerJorge Aparicio, Ramón de las Peñas, José María Vicent, et al.
Clinical Colorectal Cancer|March 7, 2003
Analysis of clinical prognostic factors for survival and time to progression in patients with metastatic colorectal cancer treated with 5-fluorouracil-based chemotherapyAna L Yuste, Jorge Aparicio, Angel Segura, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|September 6, 2006
Epidemiological pattern and time trends in testicular germ-cell tumors: a single institution 20-year experienceJorge Molina Saera, Jorge Aparicio Urtasun, Roberto Díaz Beveridge, et al.
Future Oncology (London, England)|July 14, 2017
Recommendations for SIR-Spheres Y-90 resin microspheres in chemotherapy-refractory/intolerant colorectal liver metastasesEnrique Aranda, Jorge Aparicio, José Ignacio Bilbao, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 2006
The sword of Damocles and the treatment of stage I seminomaTim Oliver, Graham Mead, Malcolm Mason, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|May 29, 2012
Long-term results with oral fluoropyrimidines and oxaliplatin-based preoperative chemoradiotherapy in patients with resectable rectal cancer. A single-institution experienceRobert Díaz Beveridge, Jorge Aparicio, Alejandro Tormo, et al.
Pageof 10

Showing results (21-30 of 93) with videos related to

Sort By:
Pageof 10
Medical Oncology (Northwood, London, England)|October 5, 2006
Clinical predictors of severe toxicity in patients treated with combination chemotherapy with irinotecan and/or oxaliplatin for metastatic colorectal cancer: a single center experienceRoberto Díaz, Jorge Aparicio, Jorge Molina, et al.
Journal of Clinical Medicine|December 3, 2020
Metastatic Colorectal Cancer. First Line Therapy for Unresectable DiseaseJorge Aparicio, Francis Esposito, Sara Serrano, et al.
Ginekologia Polska|February 28, 2023
Metastatic gastric cancer in a full-term pregnancyJorge Aparicio-Ponce, Sandra Salcedo-Hermoza, Sandra Aparicio-Salcedo, et al.
JOP : Journal of the Pancreas|January 14, 2014
Management of advanced pancreatic cancer with gemcitabine plus erlotinib: efficacy and safety results in clinical practiceRobert Diaz Beveridge, Vicent Alcolea, Jorge Aparicio, et al.
Oncology|August 21, 2002
Multicenter phase I study of irinotecan plus raltitrexed in patients with 5-fluorouracil-refractory advanced colorectal cancerJorge Aparicio, Ramón de las Peñas, José María Vicent, et al.
Clinical Colorectal Cancer|March 7, 2003
Analysis of clinical prognostic factors for survival and time to progression in patients with metastatic colorectal cancer treated with 5-fluorouracil-based chemotherapyAna L Yuste, Jorge Aparicio, Angel Segura, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|September 6, 2006
Epidemiological pattern and time trends in testicular germ-cell tumors: a single institution 20-year experienceJorge Molina Saera, Jorge Aparicio Urtasun, Roberto Díaz Beveridge, et al.
Future Oncology (London, England)|July 14, 2017
Recommendations for SIR-Spheres Y-90 resin microspheres in chemotherapy-refractory/intolerant colorectal liver metastasesEnrique Aranda, Jorge Aparicio, José Ignacio Bilbao, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 2006
The sword of Damocles and the treatment of stage I seminomaTim Oliver, Graham Mead, Malcolm Mason, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|May 29, 2012
Long-term results with oral fluoropyrimidines and oxaliplatin-based preoperative chemoradiotherapy in patients with resectable rectal cancer. A single-institution experienceRobert Díaz Beveridge, Jorge Aparicio, Alejandro Tormo, et al.
Pageof 10